8-K - Fulgent Genetics, Inc. (0001674930) (Filer)
Fri, Aug 2, 11:12 AM (88 days ago)
Fulgent Genetics, Inc. filed a Form 8-K on August 2, 2024, reporting its financial results for the fiscal quarter ended June 30, 2024. The company issued a press release detailing these results, which is attached as Exhibit 99.1. Additionally, Fulgent updated its investor presentation, available on its Investor Relations website, and included as Exhibit 99.2. The information provided in these exhibits is furnished but not filed, and thus not subject to Section 18 of the Securities Exchange Act of 1934. The filing also includes standard disclosures and contact information. No major corporate events, mergers, acquisitions, leadership changes, bankruptcy, or material agreements were reported.